Improving the Management of Patients with Hearing Loss by the Implementation of an NGS Panel in Clinical Practice
Authors:
- Gema García-GarcíaGGGema García-García
- Alba Berzal-SerranoABAlba Berzal-Serrano
- Piedad García-DíazPGPiedad García-Díaz
- Rebeca Villanova-AparisiRVRebeca Villanova-Aparisi
- Sara Juárez-RodríguezSJSara Juárez-Rodríguez
- Carlos de Paula-VernettaCPCarlos de Paula-Vernetta
- Laura Cavallé-GarridoLCLaura Cavallé-Garrido
- Teresa JaijoTJTeresa Jaijo
- Miguel Armengot-CarcellerMiguel Armengot-Carceller
- José M MillánJMJosé M Millán
- Elena AllerEAElena Aller
Open Access
Abstract
A cohort of 128 patients from 118 families diagnosed with non-syndromic or syndromic hearing loss (HL) underwent an exhaustive clinical evaluation. Molecular analysis was performed using targeted next-generation sequencing (NGS) with a custom panel that included 59 genes associated with non-syndromic HL or syndromic HL. Variants were prioritized according to the minimum allele frequency and classified according to the American College of Medical Genetics and Genomics guidelines. Variant(s) responsible for the disease were detected in a 40% of families including autosomal recessive (AR), autosomal dominant (AD) and X-linked patterns of inheritance. We identified pathogenic or likely pathogenic variants in 26 different genes, 15 with AR inheritance pattern, 9 with AD and 2 that are X-linked. Fourteen of the found variants are novel. This study highlights the clinical utility of targeted NGS for sensorineural hearing loss. The optimal panel for HL must be designed according to the spectrum of the most represented genes in a given population and the laboratory capabilities considering the pressure on healthcare.Keywords
Funding Information
- Institute of Health Carlos III (ISCIII) (PI19/00303)
This publication has 76 references indexed in Scilit:
- Genetic testing for hearing loss in the United States should include deletion/duplication analysis for the deafness/infertility locus at 15q15.3Molecular Cytogenetics, 2013
- Whole-Exome Sequencing Efficiently Detects Rare Mutations in Autosomal Recessive Nonsyndromic Hearing LossPLOS ONE, 2012
- Usher syndrome type 2 caused by activation of an USH2A pseudoexon: Implications for diagnosis and therapyHuman Mutation, 2011
- DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing lossHuman Mutation, 2011
- High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarraysBMC Biotechnology, 2010
- Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian familiesEuropean Journal of Human Genetics, 2009
- Sensorineural deafness and male infertility: a contiguous gene deletion syndromeJournal of Medical Genetics, 2007
- Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type IIJournal of Medical Genetics, 2006
- A Novel TECTA Mutation in a Dutch DFNA8/12 Family Confirms Genotype–Phenotype CorrelationJournal of the Association for Research in Otolaryngology, 2006
- Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient populationHuman Genetics, 2005